Amgen to open new site in Hyderabad

Amgen India will accelerate innovation and digital capabilities across Amgen’s global organisation

Amgen plans to open a new technology and innovation site in Hyderabad. The site, known as Amgen India, will accelerate digital capabilities across the global organization to further advance Amgen’s pipeline of medicines.

Amgen India will be located in HITEC City, a suburb of Hyderabad, occupying six floors of the RMZ Spire Tower 110. The site can accommodate up to 3,000 people and will be operational in Q4 2024.

"At a time when a quickly ageing global population needs more innovation, the convergence of biotechnology and technology is enabling Amgen to work with greater speed, confidence, and efficiency — an incredibly exciting milestone for which we have been preparing for over a decade,” said David M Reese, Executive VP and CTO, Amgen.

Amgen India will initially build and accelerate new technology solutions and digital capabilities at scale that will enhance efficiencies across the enterprise. The site will offer roles that strengthen key areas of Amgen’s business, including AI, data science, life science and other additional global capabilities over time.

“Amgen’s new site in Hyderabad underscores the city’s position as a hub for innovation and technology,” said Telangana Chief Minister, Anumula Revanth Reddy.